EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The long noncoding RNA VIM-AS1 and nucleoporin Nup358/RanBP2 regulate SMAD nuclear accumulation during TGF-β signaling

Dorival Mendes Rodrigues-Junior iD, Mohamad Moustafa Ali, Yuka Itoh, Mafalda Sousa Ferreira, Johan Heldin iD, Hao Fu, André Hoelz, Carl-Henrik Heldin, Aristidis Moustakas iD

Nucleic Acids Research · 2026

DOI: 10.1093/nar/gkaf1526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Dorival Mendes Rodrigues-Junior und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, SE-751 23 Uppsala, …. Hauptthemen laut MEDLINE: Nuclear Pore Complex Proteins, RNA, Long Noncoding, Signal Transduction, Transforming Growth Factor beta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Swedish Childhood Cancer Fund/Barncancerfonden, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transforming growth factor β (TGF-β) pathway is a developmental signaling network that regulates tissue homeostasis and malfunctions in human diseases, including cancer. TGF-β signals via two receptors, which activate SMAD and alternative signaling pathways. We show that TGF-β induces the expression of the mammalian long noncoding RNA (lncRNA) VIM-AS1 (Vimentin antisense RNA1) variant-2 (v.2) via a transcriptional SMAD-GATA6-SPI1 complex. VIM-AS1 v.1 and v.2 localize in different cell compartments, including the nuclear border. Unbiased whole transcriptomic analysis and functional gain and loss of function assays establish that VIM-AS1 v.2 enhances TGF-β signaling. Mechanistically, VIM-AS1 v.2 interacts with the nucleoporin Nup358/RanBP2, contributing to the binding of Nup358/RanBP2 to SMAD2/3 and enhancing SMAD nuclear accumulation. In the context of cancer biology, VIM-AS1 did not affect the antiproliferative actions of TGF-β, yet had an impact on the epithelial–mesenchymal transition gene program, and increased the invasion and motility of tumor cells, whereas its silencing sensitized cancer cells to chemotherapeutic agents. The molecular mechanism highlights how a lncRNA can modulate the nuclear pore’s capacity to import SMAD complexes, by facilitating their capture by Nup358/RanBP2 and thereby enhancing nuclear accumulation of SMADs with distinct isoform composition, thus promoting selectively TGF-β signaling responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear Pore Complex ProteinsRNA, Long NoncodingSignal TransductionTransforming Growth Factor betaSmad2 ProteinSmad3 ProteinSmad ProteinsHumansCell NucleusEpithelial-Mesenchymal TransitionAnimalsCell Line, TumorMolecular Chaperones

Substanzen

Nuclear Pore Complex ProteinsRNA, Long NoncodingTransforming Growth Factor betaran-binding protein 2Smad2 ProteinSmad3 ProteinSmad ProteinsMolecular Chaperones

Autor:innen und Institutionen

  • Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, SE-751 23 Uppsala, Sweden.
  • Department of Biochemistry, University of Yamanashi, Shimokato 1110, Chuo, Yamanashi 409-3898, Japan.
  • Department of Zoology, Science for Life Laboratory, Stockholm University, Tomtebodavägen 23A, SE-171 65 Stockholm, Sweden.
  • Department of Pharmaceutical Biosciences, Uppsala University, Husargatan 3, SE-75124 Uppsala, Sweden.
  • Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA 91125, United States.
  • Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA, United States.

ORCID-Profile: Dorival Mendes Rodrigues-Junior, Johan Heldin, Aristidis Moustakas

Förderung

  • Swedish Cancer Society
  • Swedish Childhood Cancer Fund/Barncancerfonden
  • European Research Council
  • Lars Hierta Memorial Foundation
  • The Sigurd and Elsa Golje Memorial Foundation
  • KAKENHI
  • Swedish Cancer Fund/Cancerfonden
  • Uppsala University

Zitieren

APA

Rodrigues-Junior, D. M., Ali, M. M., Itoh, Y., Ferreira, M. S., Heldin, J., Fu, H., Hoelz, A., Heldin, C. H., & Moustakas, A. (2026). The long noncoding RNA VIM-AS1 and nucleoporin Nup358/RanBP2 regulate SMAD nuclear accumulation during TGF-β signaling. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1526

Vancouver

Rodrigues-Junior DM, Ali MM, Itoh Y, Ferreira MS, Heldin J, Fu H, et al. The long noncoding RNA VIM-AS1 and nucleoporin Nup358/RanBP2 regulate SMAD nuclear accumulation during TGF-β signaling. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1526

BibTeX
@article{RodriguesJunior2026,
  author = {Rodrigues-Junior, Dorival Mendes and Ali, Mohamad Moustafa and Itoh, Yuka and Ferreira, Mafalda Sousa and Heldin, Johan and Fu, Hao and Hoelz, André and Heldin, Carl-Henrik and Moustakas, Aristidis},
  title = {The long noncoding RNA VIM-AS1 and nucleoporin Nup358/RanBP2 regulate SMAD nuclear accumulation during TGF-β signaling},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkaf1526}
}
Kostenlos starten →